Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dorzolamide (trusopt) (1 trial)
timolol (blocadren) (1 trial)
Edema (Phase 2)
Macular Degeneration (Phase 2)
Macular Edema (Phase 2)
Retinal Vein Occlusion (Phase 2)
Wet Macular Degeneration (Phase 2)
Trials (1 total)
Trial APIs (2 total)